Merck has entered the home stretch with its consumer unit sale, and the deal may be even bigger than previous reports have hinted. According to <em>Reuters</em>, the unit could go for close to $14 billion–a number that could climb even higher as front-runners Bayer and Reckitt Benckiser duke it out.
written on 28.04.2014